Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis
- PMID: 36072627
- PMCID: PMC9402376
- DOI: 10.1155/2022/8089914
Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis
Abstract
Objective: The aim of the study was to analyze the efficacy of double-low dynamic contrast-enhanced CT (DCE-CT) and hepatic extracellular volume fraction (fECV) in the diagnosis of liver fibrosis (LF).
Methods: A total of 200 patients with LF and cirrhosis who underwent the histopathological examination of liver biopsy and multiphase DCE-CT of the liver at the same time in our hospital (January 2020-December 2020) were selected as the research subjects, and the degree of liver fibrosis was staged according to pathological criteria to analyze the clinical diagnostic value of double-low DCE-CT and fECV.
Results: Compared with the S2-S4 group, the S1 group had obviously higher Eaorta and HCT values (P < 0.05), a lower fECV value (P < 0.001), and lower serum IVC and LN levels (P < 0.001). Serum IVC and LN levels were positively correlated with fECV (r 1 = 0.803 and r 2 = 0.890; P < 0.001). The fECV had the highest specificity and negative predictive value in the diagnosis of S1 and had the highest sensitivity and positive predictive value in the diagnosis of S2-S4.
Conclusion: The double-low DCE-CT and fECV can provide a reliable basis for the clinical diagnosis of LF, and their results will provide a new direction for the treatment of LF and have a high application value in the clinical practice.
Copyright © 2022 Zhandong Liang et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures




References
-
- Montazeri G., Rohban N., Sotoudeh M., Massarrat S. Abdominal ultrasound combined with laboratory tests as a reliable, easily accessible and cost-effective way of assessing the stages of liver fibrosis and cirrhosis. Archives of Iranian Medicine . 2022;25(2):118–123. doi: 10.34172/aim.2022.19. - DOI - PubMed
-
- Yan L. T., Wang L., Yao J., et al. Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection. Medicine (Baltimore) . 2020;99(8) doi: 10.1097/md.0000000000019248. - DOI - PMC - PubMed
-
- Chen S., Jiang T. Preoperative noninvasive assessment for liver fibrosis in hepatocellular carcinoma patients with chronic hepatitis B: comparison of two-dimensional shear-wave elastography with serum liver fibrosis models. European Journal of Radiology . 2020;133 doi: 10.1016/j.ejrad.2020.109386.109386 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical